Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
115.00    3.50 (3.14%)
Bid:
112.00
Ask:
118.00
Spread: 6.00 (5.357%)
Market Cap: £69.19m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Share Incentive Plan

10 May 2021 07:00

RNS Number : 9913X
Intercede Group PLC
10 May 2021
 

Intercede Group plc

 

("Intercede" or the "Company")

 

Share Incentive Plan

 

Further to the announcement dated 10 March 2021, the Company confirms that, following the completion of the commitment to purchase Partnership Shares with an associated award of Matching Shares, the interests of Klaas van der Leest and Andrew Walker in the ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") are as follows:

 

Previous Shareholding

Partnership & Matching Shares

Revised Shareholding

% of Issued Share Capital

Klaas van der Leest

59,806

3,600

63,406

0.11%

Andrew Walker

1,613,737

3,600

1,617,337

2.83%

The notification below, which has been made in accordance with the requirements of the Market Abuse Regulation, provides further detail.

ENQUIRIES

 

Intercede Group plc

Tel. +44 (0)1455 558111

Klaas van der Leest, Chief Executive

Andrew Walker, Finance Director

finnCap

Tel. + 44 (0)20 7220 0500

Stuart Andrews / Simon Hicks, Corporate Finance

Tim Redfern / Charlotte Sutcliffe, ECM

 

About Intercede

 

Intercede is a cybersecurity company specialising in digital identities, derived credentials and access control, enabling digital trust in a mobile world.

 

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

 

Our vision is to make the highest levels of cybersecurity available to organizations and consumers alike, solving complexity and scalability issues by managing high volumes of digital credentials.

 

We have been delivering trusted solutions to high profile customers for over 20 years. Our team of experts has deployed millions of identities to governments, most of the largest aerospace and defence corporations, and major financial services and healthcare organizations, as well as leading telecommunications, cloud services and information technology firms, providing industry-leading employee and customer credential management systems.

 

For more information visit: www.intercede.com

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Klaas van der Leest

CEO

2.

Reason for the Notification

a)

Position/status

See 1(a) above

 

 

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Intercede Group plc

 

b)

LEI

213800VFMNCYCDQ65C90

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 pence

Identification code

GB0003287249

b)

Nature of the transactions

Purchase of Partnership & Matching Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

100.0p

3,600

 

 

d)

Aggregated information:

· Aggregated volumes

· Prices

See 4(c)

 

 

e)

Date of the transaction

6 May 2021

 

 

f)

Place of the transaction

Outside of trading venue

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Walker

Finance Director

2.

Reason for the Notification

a)

Position/status

See 1(a) above

 

 

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Intercede Group plc

 

b)

LEI

213800VFMNCYCDQ65C90

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 pence

Identification code

GB0003287249

b)

Nature of the transactions

Purchase of Partnership & Matching Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

100.0p

3,600

 

 

d)

Aggregated information:

· Aggregated volumes

· Prices

See 4(c)

 

 

e)

Date of the transaction

6 May 2021

 

 

f)

Place of the transaction

Outside of trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAXSXEEDFEFA
Date   Source Headline
5th Feb 20097:00 amRNSPositive Trading Update
12th Jan 20097:00 amRNSContract with BT for NHS Nat'l Data Spine
8th Jan 20097:00 amRNSIntercede Technology Used by Queensland Police
15th Dec 20089:45 amRNSDirector's Share Purchase
15th Dec 20087:00 amRNSNew Contract with Lockheed Martin
9th Dec 20087:00 amRNSInterim Results
4th Dec 20087:00 amRNSNew Contracts
25th Nov 20087:00 amRNSNew Reseller Agreement
17th Nov 20087:00 amRNSNew Reseller Partnership
22nd Oct 20087:00 amRNSRe: US Maritime Credentialing Program
6th Oct 20087:00 amRNSStatement Re ActivIdentity Patent Claim
6th Oct 20087:00 amRNSPositive Trading Update
29th Sep 20087:00 amRNSSubcontract With Lockheed Martin
17th Sep 200810:37 amRNSDirector/PDMR Shareholding
27th Aug 200810:26 amRNSDirector/PDMR Shareholding
20th Aug 20087:00 amRNSAppointment of Global Sales D
25th Jul 20087:00 amRNSDirector/PDMR Shareholding
24th Jul 20087:00 amRNSTrading Update
30th May 20087:00 amRNSTotal Voting Rights
20th May 20087:00 amRNSFinal Results
14th May 20087:00 amRNSAdditional Listing
2nd May 200810:33 amRNSResponse to Press Speculation
11th Apr 20087:00 amRNSTrading Update
14th Feb 20087:00 amRNSTrading Update
17th Dec 200711:58 amRNSDirector Share Dealings
11th Dec 20077:01 amRNSInterim Results
3rd Oct 20077:00 amRNSTrading Update
6th Sep 20077:01 amRNSFurther Re Licence
30th Aug 20077:01 amRNSNew Licence Agreement
16th Aug 200710:01 amRNSAIM Rule 26
31st May 20077:00 amRNSTotal Voting Rights
25th May 20077:02 amRNSFinal Results
16th May 20077:01 amRNSPlacing
19th Apr 20075:25 pmRNSHolding(s) in Company
27th Mar 20077:02 amRNSTrading Update
19th Dec 200611:33 amRNSFurther US Government Win
18th Dec 20061:18 pmRNSDirector/PDMR Shareholding
14th Dec 20067:01 amRNSInterim Results
8th Dec 200611:43 amRNSTotal Voting Rights
27th Nov 20067:31 amRNSRe Gemalto Partnership in US
23rd Nov 200611:16 amRNSFurther US Government Wins
20th Nov 20067:02 amRNSNew US Government Contracts
16th Nov 20067:03 amRNSNew US Government Contract
23rd Oct 20067:01 amRNSContract Update
9th Oct 20067:01 amRNSUS Government Contract Win
1st Jun 20067:01 amRNSPreliminary Results
31st Mar 200612:00 pmRNSDirectorate Change
31st Mar 20067:02 amRNSTrading Statement
26th Jan 200610:38 amRNSFurther re OEM Agreement
20th Dec 200511:29 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.